EUVIMEDEUVIMED entdecken
Crossref

Initial Single‐Centre Experience With the Abbott Pro‐Style Closure Device for Percutaneous Decannulation Following Venoarterial Extracorporeal Membrane Oxygenation Weaning

Dushan Miladinovic iD, Luca Borruso, David A Robinson, Timothy Shiraev

ANZ Journal of Surgery · 2026

DOI: 10.1111/ans.70445 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2026. Verfasst von Dushan Miladinovic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Royal Prince Alfred Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Device Removal, Vascular Closure Devices, Heart Failure. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Venoarterial extracorporeal membrane oxygenation (VA‐ECMO) provides temporary circulatory support for patients with severe cardiac failure. Traditionally, decannulation involves open surgical cut‐down of the common femoral artery, which carries a high risk of wound complications. Percutaneous techniques using vascular closure devices have emerged as a less invasive alternative. This pilot study evaluates the feasibility and early outcomes of a percutaneous VA‐ECMO decannulation technique using the Abbott Pro‐Style closure device, compared with surgical cut‐down.

Methods

A retrospective, single‐centre review was conducted of patients undergoing percutaneous VA‐ECMO decannulation at Royal Prince Alfred Hospital between November 2023 and July 2024. Patients were matched by age and sex to a control group treated with surgical cut‐down. Data included demographics, ECMO indication and duration, procedural characteristics, vascular complications and groin wound outcomes.

Results

The percutaneous technique was performed in 15 patients (mean age 56.7 ± 13.9 years). Technical success was achieved in 87% ( n = 13), with two cases converted to open surgery due to device failure and haemorrhage. Mean procedure time was 74.3 ± 26.3 min versus 101.5 ± 47.2 min for surgical cut‐down ( p = 0.06). Groin wound complication occurred in one percutaneous patient compared to five surgical patients ( p = 0.07). ICU stay and survival to discharge were comparable between the groups.

Conclusion

This early experience supports the feasibility of percutaneous VA‐ECMO decannulation using the Abbott Pro‐Style closure device, with promising signals toward reduced wound complications and shorter procedure times. Larger prospective studies are needed to confirm these preliminary findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationDevice RemovalVascular Closure DevicesHeart FailureHumansMaleFemaleMiddle AgedRetrospective StudiesPilot ProjectsAgedFemoral ArteryFeasibility StudiesAdultTreatment Outcome

Autor:innen und Institutionen

  • Royal Prince Alfred Hospital, Sydney, Australia.
  • Department of Vascular Surgery, Royal Prince Alfred Hospital, Sydney, Australia.

ORCID-Profile: Dushan Miladinovic

Zitieren

APA

Miladinovic, D., Borruso, L., Robinson, D. A., & Shiraev, T. (2026). Initial Single‐Centre Experience With the Abbott Pro‐Style Closure Device for Percutaneous Decannulation Following Venoarterial Extracorporeal Membrane Oxygenation Weaning. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70445

Vancouver

Miladinovic D, Borruso L, Robinson DA, Shiraev T. Initial Single‐Centre Experience With the Abbott Pro‐Style Closure Device for Percutaneous Decannulation Following Venoarterial Extracorporeal Membrane Oxygenation Weaning. ANZ Journal of Surgery. 2026. doi:10.1111/ans.70445

BibTeX
@article{Miladinovic2026,
  author = {Miladinovic, Dushan and Borruso, Luca and Robinson, David A and Shiraev, Timothy},
  title = {Initial Single‐Centre Experience With the Abbott Pro‐Style Closure Device for Percutaneous Decannulation Following Venoarterial Extracorporeal Membrane Oxygenation Weaning},
  journal = {ANZ Journal of Surgery},
  year = {2026},
  doi = {10.1111/ans.70445}
}
Kostenlos starten →